Short Communications
Vol. 2 No. 3 (2016)
https://doi.org/10.4081/gc.2016.6156

The key points for treatment of Parkinsonism in older persons

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 12 July 2016
Accepted: 14 November 2016
Published: 11 January 2017
3031
Views
2180
Downloads
10710
HTML
Parkinsonism, cognitive impairment, cogwheel rigidity, lead-pipe rigidity.

Authors

Fulvio Lauretani
flauretani@ao.pr.it
Internal Medicine and Critical Subacute Care Unit, Laboratory of Disability Prevention, Department of Geriatrics and Rehabilitation, University-Hospital of Parma; Department of Clinical and Experimental Medicine, University of Parma, Italy.
Andrea Ticinesi
Internal Medicine and Critical Subacute Care Unit, Laboratory of Disability Prevention, Department of Geriatrics and Rehabilitation, University-Hospital of Parma; Department of Clinical and Experimental Medicine, University of Parma, Italy.
Tiziana Meschi
Internal Medicine and Critical Subacute Care Unit, Laboratory of Disability Prevention, Department of Geriatrics and Rehabilitation, University-Hospital of Parma; Department of Clinical and Experimental Medicine, University of Parma, Italy.
Marcello Maggio
Department of Clinical and Experimental Medicine, University of Parma; Department of Clinical Geriatrics and Geriatric Rehabilitation, University-Hospital of Parma, Italy.
Signs and symptoms of Parkinsonism have a high prevalence in older persons. Parkinsonism is associated with negative outcomes in the elderly and there is still uncertainty about when and how to start levodopa in these conditions. The diagnosis of idiopathic Parkinson disease is often not pursued in the oldest old. The coexistence of both motor and cognitive impairment is the strongest factor limiting the initiation of treatment with levodopa and/or dopamine agonists in a geriatric setting, given the possibility of producing psychotic symptoms, such as visual hallucinations. It seems reasonable to perform at least one attempt to administer levodopa in older persons with parkinsonism, especially when symptoms and motility disorders are evident, in order to try to obtain an improvement in walking speed and balance. Important signs that should guide treatment for Parkinsonism in older persons are the presence of line-pipe rigidity and cogwheel rigidity.

Downloads

Download data is not yet available.

How to Cite



The key points for treatment of Parkinsonism in older persons. (2017). Geriatric Care, 2(3). https://doi.org/10.4081/gc.2016.6156

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.